Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	78.35	9.77	5.48
Graham Fair Price	29.21	7825.15	6056.23
PEG	670.44	0.05	< 0.005
Price/Book	-4.93	0.43	0.45
Price/Cash Flow	285491.35	72018.09	25.22
Prices/Earnings	-40.77	2.88	4.87
Price/Sales	-2.27	2.71	2.77
Price/FCF	285491.35	72018.09	25.22
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-6.38	0.31	0.33
Operating Margin	-10.89	0.18	0.20
ROA	57.28	0.03	0.02
ROE	0.02	0.04	60.51
ROIC	0.03	0.02	-25.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.52	-0.21	145.09
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	32.59	-0.12	-99.64
EPS QOQ	8.29	0.64	-92.31
FCF QOQ	2.66	-1.00	-62.47
Revenue QOQ	0.20	< 0.005	-96.05
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	51.30	59.07	15.15
Days Sales Outstanding (DSO)	88.57	98.28	10.96
Inventory Turnover	1.75	1.52	-13.15
Debt/Capitalization	0.01	0.02	45.27
Quick Ratio	4.46	3.73	-16.38
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8403.28	8570.01	1.98
Cash	2117.94	2189.58	3.38
Capex	-101.05	-80.21	20.62
Free Cash Flow	149.70	0.05	-99.97
Revenue	1362.06	1351.20	-0.80
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	5.22	4.41	-15.51
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.72	-1.65	65.07
Naive Interpretation	Member

06 - Financial Health · Bad

Rating